ModelEdge

Regeneron Pharmaceuticals, Inc.
REGN
Filing Type10-Q
Filing Date10/27/2025
Updated10/28/25, 4:56 AM

Filing

10-Q
Earnings Release

Exhibits

10-QQ3
EX-31.1CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)
EX-31.2CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)
EX-32CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C SECTION 1350